|
|
J Clin Invest. 1979 July; 64(1): 138–144. doi: 10.1172/JCI109432. | PMCID: PMC372099 |
Membrane Fluidity in Human and Mouse Chediak-Higashi Leukocytes Richard A. Haak, Leah M. Ingraham, Robert L. Baehner, and Laurence A. Boxer Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46223 Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46223 Abstract Polymorphonuclear leukocytes from humans and mice with the Chediak-Higashi syndrome were characterized by spin label electron spin resonance spectrometry. Our results suggest that cells from afflicted mice and humans have membranes more fluid than controls. Order parameters for a spin label that probes near the membrane surface were 0.652 for normals and 0.645 for two Chediak-Higashi patients. Cells from Chediak-Higashi mice showed similar differences, as did isolated plasma membrane fractions. An increased membrane fluidity was also detected with a spin label that probes deeper in the bilayer. In vitro treatment of Chediak-Higashi mouse cells with 0.01 M ascorbate increased the order parameter to normal levels. In vitro incubation of mouse Chediak-Higashi cells with glucose oxidase increased the order parameter, similar to the effect of ascorbate. This increase was abolished when catalase was added to the incubation medium. In vitro incubation with dibutyryl cyclic guanosine monophosphate (1 μM to 0.1 mM) did not normalize order parameters. These results indicate that fluidity of Chediak-Higashi cell membranes was affected by treatments expected to alter the oxidation: reduction potential of the environment but was not affected by treatments expected to alter the ratio of intracellular cyclic nucleotides. The latter treatment would affect microtubule assembly. Therefore, it appears that the membrane fluidity abnormalities as demonstrated by electron spin resonance and the earlier demonstrated microtubule dysfunctions characteristic of Chediak-Higashi cells are coexisting defects and are probably not directly related. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Blume RS, Wolff SM. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine (Baltimore). 1972 Jul;51(4):247–280. [PubMed]
- Boxer LA, Watanabe AM, Rister M, Besch HR, Jr, Allen J, Baehner RL. Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med. 1976 Nov 4;295(19):1041–1045. [PubMed]
- Boxer LA, Allen JM, Watanabe AM, Besch HR, Jr, Baehner RL. Role of microtubules in granulocyte adherence. Blood. 1978 Jun;51(6):1045–1050. [PubMed]
- Oliver JM, Zurier RB, Berlin RD. Concanavalin a cap formation on polymorphonuclear leukocytes of normal and beige (chediak-higashi) mice. Nature. 1975 Feb 6;253(5491):471–473. [PubMed]
- Oliver JM, Zurier RB. Correction of characteristic abnormalities of microtubule function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists. J Clin Invest. 1976 May;57(5):1239–1247. [PubMed]
- MARTIN SP, GREEN R. Methods for the study of surviving leukocytes: A. Preparation of cell suspension. Methods Med Res. 1958;7:136–138. [PubMed]
- Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed]
- Avruch J, Wallach DF. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim Biophys Acta. 1971 Apr 13;233(2):334–347. [PubMed]
- Gaffney BJ, McNamee CM. Spin-label measurements in membranes. With appendix: a use of computers in EPR spectroscopy. Methods Enzymol. 1974;32(Pt B):161–198. [PubMed]
- Kury PG, McConnell M. Regulation of Membrane Flexibility in Human Erythrocytes. Biochemistry. 1975 Jul;14(13):2798–2803. [PubMed]
- Stone TJ, Buckman T, Nordio PL, McConnell HM. Spin-labeled biomolecules. Proc Natl Acad Sci U S A. 1965 Oct;54(4):1010–1017. [PubMed]
- Cooper RA. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med. 1977 Aug 18;297(7):371–377. [PubMed]
- Inbar M, Goldman R, Inbar L, Bursuker I, Goldman B, Akstein E, Segal P, Ipp E, Ben-Bassat I. Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components. Cancer Res. 1977 Sep;37(9):3037–3041. [PubMed]
- Sato B, Nishikida K, Samuels LT, Tyler FH. Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. J Clin Invest. 1978 Feb;61(2):251–259. [PubMed]
- KRITZLER RA, TERNER JY, LINDENBAUM J, MAGIDSON J, WILLIAMS R, PRESIG R, PHILLIPS GB. CHEDIAK-HIGASHI SYNDROME. CYTOLOGIC AND SERUM LIPID OBSERVATIONS IN A CASE AND FAMILY. Am J Med. 1964 Apr;36:583–594. [PubMed]
- Kanfer JN, Blume RS, Yankee RA, Wolff SM. Alteration of sphingolipid metabolism in leukocytes from patients with the Chediak-Higashi syndrome. N Engl J Med. 1968 Aug 22;279(8):410–413. [PubMed]
- Kanfer JN, Richards R, Kampine JP, Handmaker S, Yankee RA. Alteration of e sphingolipid content in leucocytes from patients with Chediak-Higashi syndrome. Life Sci. 1967 Dec 15;6(24):2661–2664. [PubMed]
- Rausch PG, Pryzwansky KB, Spitznagel JK. Immunocytochemical identification of azurophilic and specific granule markers in the giant granules of Chediak-Higashi neutrophils. N Engl J Med. 1978 Mar 30;298(13):693–698. [PubMed]
- Rozenszajn LA, David EB, Sela SB. Large granules and lysosomal fusion in human Chediak-Higashi white blood cells. Acta Haematol. 1977;57(5):279–289. [PubMed]
- Lucy JA. The fusion of biological membranes. Nature. 1970 Aug 22;227(5260):815–817. [PubMed]
- Peterkofsky B, Prather W. Cytotoxicity of ascorbate and other reducing agents towards cultured fibroblasts as a result of hydrogen peroxide formation. J Cell Physiol. 1977 Jan;90(1):61–70. [PubMed]
- Stossel TP, Mason RJ, Smith AL. Lipid peroxidation by human blood phagocytes. J Clin Invest. 1974 Sep;54(3):638–645. [PubMed]
- Dobretsov GE, Borschevskaya TA, Petrov VA, Vladimirov YA. The increase of phospholipid bilayer rigidity after lipid peroxidation. FEBS Lett. 1977 Dec 1;84(1):125–128. [PubMed]
- Boxer LA, Rister M, Allen JM, Baehner RL. Improvement of Chediak-Higashi leukocyte function by cyclic guanosine monophosphate. Blood. 1977 Jan;49(1):9–17. [PubMed]
- Weissmann G, Goldstein I, Hoffstein S, Tsung PK. Reciprocal effects of cAMP and cGMP on microtubule-dependent release of lysosomal enzymes. Ann N Y Acad Sci. 1975 Jun 30;253:750–762. [PubMed]
- Oliver JM. Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome. Am J Pathol. 1976 Nov;85(2):395–418. [PubMed]
- Bourguignon LY, Singer SJ. Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands. Proc Natl Acad Sci U S A. 1977 Nov;74(11):5031–5035. [PubMed]
|